The Eduardo Anitua Foundation for Biomedical Research is to hold a conference on regenerative medicine, cell therapy and tissue engineering in Vitoria-Gasteiz on 31 October. This inaugural International Symposium on Translational Regenerative Medicine will see the presentation of the latest technologies and applications in regenerative medicine as well as clinical cases and tests in which the most recent developments in cell signals and stem cells have been applied in different areas of medicine such as traumatology, sports medicine, oral and maxillofacial surgery, ophthalmology, the regeneration of skin and the respiratory tract, and cardiovascular surgery, to name but a few.

A number of leading speakers from around the world will be attending the event, including Juan Carlos Izpisúa (Director of the Barcelona Regenerative Medicine Centre and the head of the Gene Expression Laboratory at the Salk Institute, USA), Augusto Silva (General Director of the Advanced Therapies and Transplants Centre), Katrina L. Kelner (Editor of the journal Science Translational Medicine (STM), USA), Carlos Simón (lecturer in obstetrics and gynaecology and Scientific Director at the Valencian Institute of Infertility and the IVI Foundation, and Eduardo Anitua (Scientific Director of the Basque biocompany BTI Biotechnology Institute).

Regenerative medicine, tissue engineering and, in a broader sense, the development of technologies with a clear translational orientation towards tissue repair and regeneration are all challenges facing us in the 21st century. It is for this reason that the Eduardo Anitua Foundation for Biomedical Research has sought to bring together all the players operating in this field by organising this, the first International Symposium on Translational Regenerative Medicine.